Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine

Floreth Timothy, Stern Eric, Tu Yingli, Stern Randi, Garrity, Bhorade, White

Description

While lung transplantation is an increasingly utilized therapy for advanced lung diseases, chronic rejection in the form of Bronchiolitis Obliterans Syndrome (BOS) continues to result in significant allograft dysfunction and patient mortality. Despite correlation of clinical events with eventual development of BOS, the causative pathophysiology remains unknown. Airway epithelial cells within the region of inflammation and fibrosis associated with BOS may have a participatory role. Methods Transplant derived airway epithelial cells differentiated in air liquid interface culture were treated with IL-1β and/or cyclosporine, after which secretion of cytokines and growth factor and gene expression for markers of epithelial to mesenchymal transition were analyzed. Results Secretion of IL-6, IL-8, and TNF-α, but not TGF-β1, was increased by IL-1β stimulation. In contrast to previous studies using epithelial cells grown in submersion culture, treatment of differentiated cells in ALI culture with cyclosporine did not elicit cytokine or growth factor secretion, and did not alter IL-6, IL-8, or TNF-α production in response to IL-1β treatment. Neither IL-1β nor cyclosporine elicited expression of markers of the epithelial to mesenchymal transition E-cadherin, EDN-fibronectin, and α-smooth muscle actin. Conclusion Transplant derived differentiated airway epithelial cell IL-6, IL-8, and TNF-α secretion is not regulated by cyclosporine in vitro ; these cells thus may participate in local inflammatory responses in the setting of immunosuppression. Further, treatment with IL-1β did not elicit gene expression of markers of epithelial to mesenchymal transition. These data present a model of differentiated airway epithelial cells that may be useful in understanding epithelial participation in airway inflammation and allograft rejection in lung transplantation.

Informations

• Publié par: biomed
• Publié le: 01 janvier 2011
• Nombre de lectures: 7
• Langue: English
• Poids de l'ouvrage: 1 Mo

Extrait

Florethet al.Respiratory Research2011,12:44 http://respiratoryresearch.com/content/12/1/44

R E S E A R C H

Open Access

Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine † †* Timothy Floreth , Eric Stern , Yingli Tu, Randi Stern, Edward R Garrity Jr, Sangeeta M Bhorade and Steven R White

Abstract Background:While lung transplantation is an increasingly utilized therapy for advanced lung diseases, chronic rejection in the form of Bronchiolitis Obliterans Syndrome (BOS) continues to result in significant allograft dysfunction and patient mortality. Despite correlation of clinical events with eventual development of BOS, the causative pathophysiology remains unknown. Airway epithelial cells within the region of inflammation and fibrosis associated with BOS may have a participatory role. Methods:Transplant derived airway epithelial cells differentiated in air liquid interface culture were treated with IL1band/or cyclosporine, after which secretion of cytokines and growth factor and gene expression for markers of epithelial to mesenchymal transition were analyzed. Results:Secretion of IL6, IL8, and TNFa, but not TGFb1, was increased by IL1bstimulation. In contrast to previous studies using epithelial cells grown in submersion culture, treatment of differentiated cells in ALI culture with cyclosporine did not elicit cytokine or growth factor secretion, and did not alter IL6, IL8, or TNFa production in response to IL1btreatment. Neither IL1bnor cyclosporine elicited expression of markers of the epithelial to mesenchymal transition Ecadherin, EDNfibronectin, andasmooth muscle actin. Conclusion:Transplant derived differentiated airway epithelial cell IL6, IL8, and TNFasecretion is not regulated by cyclosporinein vitro; these cells thus may participate in local inflammatory responses in the setting of immunosuppression. Further, treatment with IL1bdid not elicit gene expression of markers of epithelial to mesenchymal transition. These data present a model of differentiated airway epithelial cells that may be useful in understanding epithelial participation in airway inflammation and allograft rejection in lung transplantation.

Background Lung transplantation is an accepted therapeutic approach to selected endstage lung diseases. Despite improvement in perioperative and early posttransplant outcomes, lung transplant recipients do not obtain the equivalent allograft longevity and resultant survival con ferred upon other solid organ recipients [1]. Longterm outcomes in lung transplantation have been complicated by chronic rejection in the form of Bronchiolitis Obliter ans Syndrome (BOS) with 50% of patients affected at five years [2,3].

* Correspondence: [e-mail] †Contributed equally Section of Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, IL 60637, USA

Clinical events that correlate with the eventual devel opment of BOS include primary graft dysfunction, acute rejection, viral respiratory infections, and gastroesopha geal reflux although the mechanisms by which these events contribute to BOS have not been discerned [4]. While the histopathology of BOS has been described, a complete understanding of the causative pathophysiol ogy remains elusive. Early inflammatory lesions in BOS are characterized by bronchiolar epithelial invasion by mononuclear cells with marked neutrophilia. After reso lution of inflammation, fibrosis of the epithelium and airway lumen become the dominant histopathology [5]. Murine tracheal transplantation models suggest that airway epithelial cells (AEC) are a target of immune mediated injury in BOS [6]. Sera from lung transplant recipients with BOS have been shown to contain

© 2011 Floreth et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.